Feature | November 18, 2013

Medtronic to Resume Sales of CoreValve System in Germany

German court discontinues injunction involving Edwards Lifesciences patent lawsuit

heart valve repair structural hybrid or medtronic corevalve edwards lifesciences

November 18, 2013 — A German court ordered Nov. 14 the discontinuation of a prior court ruling that prohibited Medtronic from commercially marketing or selling the CoreValve transcatheter aortic valve replacement (TAVR) system in Germany since Aug. 26, 2013.
 
"Medtronic is very pleased with this decision as it will ensure that patients in Germany who need aortic valve replacement will have access to this life-saving therapy," said John Liddicoat, M.D., senior vice president, Medtronic and president, Medtronic Structural Heart Business. "As a result of the ruling, Medtronic will resume distribution of the CoreValve System in Germany."
 
The Higher Regional Court of Karlsruhe explained that, due to the European Patent Office (EPO) preliminary opinion that the Edwards Lifesciences’ EP2055266 Spenser patent claims are not valid, it could not assume "with sufficient likelihood" that the Spenser patent is valid.
 
Medtronic will post the €5 million bond required by the order as soon as possible and then resume sales in Germany.
 
For more information: www.medtronic.com

Related Content

Feature | Heart Valve Technology

July 8, 2021 – Xeltis announced it started the first pivotal trial for a synthetic polymer restorative pulmonary valve ...

Home July 08, 2021
Home
News | Heart Valve Technology

June 2, 2021 – LivaNova announced June 1 it successfully completed the initial closing of the divestiture of its heart ...

Home June 02, 2021
Home
News | Heart Valve Technology

May 4, 2021 – A new study, presented at the 2021 American Association for Thoracic Surgery (AATS) 101st annual meeting ...

Home May 04, 2021
Home
News | Heart Valve Technology

March 18, 2020 — A groundbreaking new study led by University of Minnesota Twin Cities researchers from both the College ...

Home March 18, 2021
Home
News | Heart Valve Technology

February 4, 2021 — Transcatheter aortic valve replacement (TAVR) has historically only been used with caution in the ...

Home February 04, 2021
Home
News | Heart Valve Technology

January 20, 2021 — The U.S. Centers for Medicare and Medicaid Services (CMS) revised its National Coverage Determination ...

Home January 20, 2021
Home
News | Heart Valve Technology

December 14, 2020 - Foldax Inc. today announced that the U.S. Food and Drug Administration (FDA) has granted an ...

Home December 14, 2020
Home
Feature | Heart Valve Technology

November 17, 2020 — Since the approval of the first transcatheter aortic valve replacement (TAVR) device in 2011, more ...

Home November 17, 2020
Home
Feature | Heart Valve Technology | Dave Fornell, Editor

November 17, 2020 — Boston Scientific Corp. announced today it is immediately retiring the entire Lotus Edge ...

Home November 17, 2020
Home
Videos | Heart Valve Technology

David Cohen, M.D., presents late-breaking data from the STS/ACC Transcatheter Valve Registry (TVT) showing the impact of ...

Home October 19, 2020
Home
Subscribe Now